Atlas Trials

Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

Clinical trial NCT05983991 · RECRUITING

Trial details

NCT number
NCT05983991
Sponsor
Institut Claudius Regaud
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
GATA2 Gene Mutation
Start date
2023-12-07
Primary completion
2033-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.